The markets traded mixed during the midday with the Dow losing 17 points to 16,137 as February homebuilder confidence fell. Nasdaq gained 29 points to 4273.
On the upside
JA Solar Holdings (Nasdaq: JASO) announced that its multi-crystalline silicon solar cells exceeded 19% conversion efficiency.
The Food and Drug Administration cited severe weather conditions for extending the action date for Chelsea Therapeutics' (Nasdaq: CHTP) New Drug Application for Northera to today, February 18.
Myriad Genetics (Nasdaq: MYGN) published data in the Journal of Urology demonstrating the accuracy of its Prolaris test in predicting metastases in prostate cancer.
On the downside
Gotham City Research wrote that Blucora's (Nasdaq: BCOR) revenue will plunge more than 60%.
LiveDeal (Nasdaq: LIVE) announced that first quarter revenue rose 4% while net loss tumbled 62% but the stock price fell.
Wolverine World Wide (NYSE: WWW) narrowed fourth quarter losses more than expected as revenue rose but the company forecast full year earnings below expectations.
In the broad market, advancing issues outpaced decliners by a margin of nearly 2 to 1 on the NYSE and by nearly 7 to 3 on Nasdaq. The broader S&P 500 added 2 points to 1840. Bitcoin slipped $27.61 or 10.96% to $251.89.
